Now Approved for Hemophilia A With Inhibitors

Watch our recent webcast featuring Dr. Guy Young and Dr. Michael Callaghan, experts in the field of hemophilia. Watch them discuss the prescribing information, safety, clinical trials, dosage, and administration of HEMLIBRA.

Broadcast on 11/29/17

HEMLIBRA Tools & Services for Healthcare Providers

HEMLIBRA resources to help you treat your patients with hemophilia A with FVIII inhibitors